MedTrace Logo

Artificial Intelligence-based Mortality Prediction Among Cancer Patients in the Hospice Ward

NCT04883879 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2021-05-12

No results posted yet for this study

Summary

The purpose of this study is to develop a novel deep-learning-based survival prediction model employing patient activity data recorded by a wearable device.

Conditions

  • End Stage Cancer

Sponsors & Collaborators

  • Ministry of Science and Technology, Taiwan

    collaborator OTHER_GOV

  • Taipei Medical University Hospital

    collaborator OTHER

  • National Yang Ming Chiao Tung University

    collaborator OTHER

  • Taipei Medical University

    lead OTHER

Principal Investigators

  • Shabbir Syed-Abdul, PhD · Taipei Medical University

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-11
Primary Completion
2021-08-31
Completion
2021-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04883879 on ClinicalTrials.gov